Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Genbody, Vieworks, Wision.
No one denies that fewer new drugs will be a consequence of the Medicare drug pricing provisions the Democrats are trying to push through the U.S. Congress ahead of the midterm election campaign season. Less attention has been paid to the negative impact on drug-device combinations and new diagnostics that accompany innovative treatments.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acclarent, Endologix, Glaukos, Pulse Biosciences.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Castle Biosciences, Cirrusdx, Congenica, Dascena, Genomoncology, Innovia, Lantheus, Milestone Scientific, Radiopharm.
RSS
